National Health Valuation
| NHI Stock | USD 77.00 0.71 0.91% |
At this time, the firm appears to be overvalued. National Health Investors secures a last-minute Real Value of $66.55 per share. The latest price of the firm is $77.0. Our model forecasts the value of National Health Investors from analyzing the firm fundamentals such as Profit Margin of 0.38 %, return on equity of 0.0993, and Current Valuation of 4.65 B as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting National Health's valuation include:
Price Book 2.8722 | Enterprise Value 4.7 B | Enterprise Value Ebitda 18.4726 | Price Sales 10.7011 | Forward PE 12.837 |
Overvalued
Today
Please note that National Health's price fluctuation is very steady at this time. Calculation of the real value of National Health Investors is based on 3 months time horizon. Increasing National Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since National Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of National Stock. However, National Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 77.0 | Real 66.55 | Target 54.86 | Hype 77.03 | Naive 74.13 |
The intrinsic value of National Health's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence National Health's stock price.
Estimating the potential upside or downside of National Health Investors helps investors to forecast how National stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of National Health more accurately as focusing exclusively on National Health's fundamentals will not take into account other important factors: When choosing an evaluation method for National Health Investors, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
National Health Cash |
|
National Valuation Trend
National Health's real value analysis enables investors to forecast the earnings more efficiently. Using both National Health's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing decisions.
National Revenue by Product
National Health Total Value Analysis
National Health Investors is now forecasted to have company total value of 4.65 B with market capitalization of 3.53 B, debt of 1.14 B, and cash on hands of 19.29 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the National Health fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4.65 B | 3.53 B | 1.14 B | 19.29 M |
National Health Investor Information
About 68.0% of the company shares are owned by institutional investors. The book value of National Health was now reported as 33.73. The company has Price/Earnings To Growth (PEG) ratio of 1.99. National Health Investors last dividend was issued on the 31st of December 2024. Based on the key indicators obtained from National Health's historical financial statements, National Health Investors is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in December.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.69 | 0.559 |
|
| |||||
| Total Cash From Operating Activities | 113.1 M | 184.4 M |
|
| |||||
| Operating Income | 96.8 M | 178.8 M |
|
|
National Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. National Health has an asset utilization ratio of 12.85 percent. This signifies that the Company is making $0.13 for each dollar of assets. An increasing asset utilization means that National Health Investors is more efficient with each dollar of assets it utilizes for everyday operations.National Health Ownership Allocation
National Health Investors maintains a total of 45.42 Million outstanding shares. Over half of National Health's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.National Health Profitability Analysis
The company reported the last year's revenue of 319.83 M. Total Income to common stockholders was 134.38 M with profit before taxes, overhead, and interest of 268.98 M.National Health Past Distributions to stockholders
About National Health Valuation
An absolute valuation paradigm, as applied to National Stock, attempts to find the value of National Health Investors based on its fundamental and basic technical indicators. By analyzing National Health's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of National Health's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of National Health. We calculate exposure to National Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of National Health's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 308.3 M | 169 M | |
| Pretax Profit Margin | 0.42 | 0.67 | |
| Operating Profit Margin | 0.56 | 0.69 | |
| Net Profit Margin | 0.42 | 0.44 | |
| Gross Profit Margin | 0.96 | 1.08 |
A single share of National Health represents a small ownership stake in the entity. As a stockholder of National, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
National Health Dividends Analysis For Valuation
As of now, National Health's Dividend Yield is increasing as compared to previous years. The National Health's current Dividend Payout Ratio is estimated to increase to 1.21, while Dividends Paid is projected to decrease to under 95.5 M. . As of now, National Health's Retained Earnings are increasing as compared to previous years. The National Health's current Earnings Yield is estimated to increase to 0.08, while Price Earnings To Growth Ratio is projected to decrease to 0.03.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 156.2 M | 95.5 M | |
| Dividend Yield | 0.06 | 0.09 | |
| Dividend Payout Ratio | 1.15 | 1.21 | |
| Dividend Paid And Capex Coverage Ratio | 1.15 | 1.44 |
There are various types of dividends National Health can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of National shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from National Health Investors directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When National pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of National Health by the value of the dividends paid out.
National Health Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 43.4 M | |
| Quarterly Earnings Growth Y O Y | -0.141 | |
| Forward Price Earnings | 12.837 |
National Health Current Valuation Indicators
Valuation refers to the process of determining the present value of National Health Investors and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value National we look at many different elements of the entity such as National's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as National Health, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use National Health's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes National Health's worth.Complementary Tools for National Stock analysis
When running National Health's price analysis, check to measure National Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Health is operating at the current time. Most of National Health's value examination focuses on studying past and present price action to predict the probability of National Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Health's price. Additionally, you may evaluate how the addition of National Health to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |